Publicaciones (25) Publicaciones de ELSA IZQUIERDO GARCÍA

2024

  1. Descriptive Analysis of Carrier and Affected Hereditary Fructose Intolerance in Women during Pregnancy

    Healthcare (Switzerland), Vol. 12, Núm. 5

  2. Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance

    Orphanet Journal of Rare Diseases, Vol. 19, Núm. 1

2023

  1. Correction: Vitamin C and folate status in hereditary fructose intolerance (European Journal of Clinical Nutrition, (2022), 76, 12, (1733-1739), 10.1038/s41430-022-01178-3)

    European Journal of Clinical Nutrition

2022

  1. Physicochemical and Microbiological Stability of Two Oral Solutions of Methadone Hydrochloride 10 mg/mL

    Molecules, Vol. 27, Núm. 9

  2. Reply letter to the editor concerning the article ‘Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance’

    Human Vaccines and Immunotherapeutics

  3. Vitamin C and folate status in hereditary fructose intolerance

    European Journal of Clinical Nutrition, Vol. 76, Núm. 12, pp. 1733-1739

2021

  1. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  2. Transferrin isoforms, old but new biomarkers in hereditary fructose intolerance

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  2. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: A retrospective case series study

    BMJ Open, Vol. 10, Núm. 11

  3. Social and health care needs in patients with hereditary fructose intolerance in Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 4, pp. 253-262

  4. The pandemyc score. An easily applicable and interpretable model for predicting mortality associated with COVID-19

    Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-10

2019

  1. Detection of galactomannan content in generic piperacillin-tazobactam products

    Infectious Diseases

2018

  1. Pharmacist as a qualified advisor in patients associations with rare diseases: Experience in hereditary fructose intolerance

    European Journal of Clinical Pharmacy

2017

  1. Drug syrups: Errors in drug labels with possible consequences in patients with heritary fructose intolerance

    Anales de Pediatria, Vol. 87, Núm. 6, pp. 351-353

  2. Jarabes de medicamentos: Errores en ficha técnica con posibles consecuencias en pacientes con intolerancia hereditaria a la fructosa

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 87, Núm. 6, pp. 351-353

2016

  1. Cross-cultural Adaptation and Validation of the Medication Regimen Complexity Index Adapted to Spanish

    Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 918-925

2014

  1. Edulcorantes en pacientes con intolerancia hereditaria a la fructosa

    Acta Pediatrica Espanola, Vol. 72, Núm. 1, pp. 15-23

2012

  1. Interacciones de los nuevos inhibidores de la proteasa para el tratamiento de la hepatitis C: telaprevir y boceprevir

    Farmacia Hospitalaria, Vol. 36, Núm. 6, pp. 469-482

2011

  1. Incidencia de bacteriemia asociada a catéter en niños hospitalizados que reciben nutrición parenteral

    Nutricion Hospitalaria, Vol. 26, Núm. 1, pp. 236-238